Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for BioCryst Pharmaceuticals, Inc. (BCRX)

« Back to company index

BCRX Chatter Timeline

Stock Ticker for BCRX

Most Active Tweeters for BCRX

UserTweets
@FlashAlert_me 3
@AmericanBanking 3
@VisualStockRSRC 3
@Allstocknews 2
@rogerthat191 1

Recent Tweets for BCRX

dakotafinancial @dakotafinancial
BioCryst Pharmaceuticals, Inc. $BCRX Given Average Recommendation of “Hold” by Brokerages https://t.co/dp62T5vPc4
July 14th 2019, 11:07am
AmericanBanking @AmericanBanking
Zacks: Brokerages Anticipate BioCryst Pharmaceuticals, Inc. $BCRX Will Post Quarterly Sales of $2.52 Million https://t.co/jfkfUKjdFx #stocks
July 14th 2019, 1:07am
AmericanBanking @AmericanBanking
Zacks: Brokerages Anticipate BioCryst Pharmaceuticals, Inc. $BCRX to Post -$0.31 Earnings Per Share https://t.co/IX48r1MpmT #stocks
July 12th 2019, 8:07pm
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Anticipate BioCryst Pharmaceuticals, Inc. $BCRX to Post -$0.31 Earnings Per Share https://t.co/A1yDftRGmo
July 12th 2019, 8:07pm
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX Given Average Rating of “Hold” by Analysts https://t.co/C0mFNWXZPf #stocks
July 9th 2019, 12:07pm
rogerthat191 @rogerthat191
$BCRX ascending triangle idea ? Will put on ? https://t.co/PbcCYdckA7
July 8th 2019, 10:07pm
InsiderAlertsIA @InsiderAlertsIA
$BCRX: New Insider Filing on Chief Business Officer MEGAN SNIECINSKI: https://t.co/ZEPcWaAstk
July 3rd 2019, 1:07pm
Allstocknews @Allstocknews
$BCRX New Form 4 for BioCryst Pharmaceutical, Inc. From our Stock News Alerts App
July 3rd 2019, 1:07pm
VisualStockRSRC @VisualStockRSRC
$BCRX - Statement of Changes in Beneficial Ownership (4) https://t.co/acEnohv95x
July 3rd 2019, 1:07pm
FlashAlert_me @FlashAlert_me
$BCRX filed SEC form 4: Insider Sniecinski Megan: https://t.co/d0OqaoNaho
July 3rd 2019, 1:07pm
StockNewsNow @StockNewsNow
$BCRX BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://t.co/z8zHhTq6Ar
July 3rd 2019, 12:07pm
Allstocknews @Allstocknews
$BCRX New Form 3 for BioCryst Pharmaceutical, Inc. From our Stock News Alerts App
July 3rd 2019, 9:07am
StockTexts @StockTexts
$BCRX BioCryst Pharmaceuticals, Inc. SEC Filing: Form 3 https://t.co/hKmTDlR5Uq
July 3rd 2019, 9:07am
VisualStockRSRC @VisualStockRSRC
$BCRX - Initial Statement of Beneficial Ownership (3) https://t.co/aWPeHYLc8h
July 3rd 2019, 9:07am
FlashAlert_me @FlashAlert_me
$BCRX filed SEC form 3: Insider Sniecinski Megan: https://t.co/0nN4BjY65O
July 3rd 2019, 9:07am
VisualStockRSRC @VisualStockRSRC
$BCRX - BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://t.co/0plQdM77vu
July 3rd 2019, 7:07am
FlashAlert_me @FlashAlert_me
$BCRX: Press Release published article on July 03, 07:15:00: BioCryst Reports Inducement Grants Under NASDAQ Listin… https://t.co/yICuiTxK9k
July 3rd 2019, 7:07am
StockNewsNow @StockNewsNow
$BCRX BioCryst Appoints Megan Sniecinski Chief Business Officer https://t.co/qyEyryJEol
July 1st 2019, 11:07am
fintel_io @fintel_io
$BCRX / BioCryst Pharmaceuticals files form 8-K https://t.co/rzpNBdvMaH - Regulation FD Disclosure, Departure of Di… https://t.co/F4uj7DkyrP
July 1st 2019, 11:07am
fintel_io @fintel_io
Also, if you are new to $BCRX here's some background for you https://t.co/eYLYjHb5y4
July 1st 2019, 11:07am
fintel_io @fintel_io
$BCRX / BioCryst Pharmaceuticals files form 8-K https://t.co/rzpNBdvMaH - Departure of Directors or Certain Officer… https://t.co/YaJRmEwBEW
July 1st 2019, 11:07am
StockTexts @StockTexts
$BCRX BioCryst Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/EjgVhmHsYN
July 1st 2019, 8:07am
filingsdb @filingsdb
New Form 8-K filed by BIOCRYST PHARMACEUTICALS INC $BCRX - https://t.co/qIjmWnD0i2
July 1st 2019, 8:07am
FlashAlert_me @FlashAlert_me
$BCRX filed form 8-K on July 01, 08:07:41: Item5.02: Departure of Election 0f Officers or Compensatory Arrangements https://t.co/Kix5CQTZ62
July 1st 2019, 8:07am
filingsdb @filingsdb
New Form 8-K filed by BIOCRYST PHARMACEUTICALS INC $BCRX - https://t.co/c02XntkgBZ
July 1st 2019, 7:07am
FlashAlert_me @FlashAlert_me
$BCRX filed form 8-K on July 01, 07:41:45: Item5.02: Departure of Election 0f Officers or Compensatory Arrangements https://t.co/gcdBv5jg00
July 1st 2019, 7:07am
Allstocknews @Allstocknews
$BCRX BioCryst Appoints Megan Sniecinski Chief Business Officer From our Stock News Alerts App
July 1st 2019, 7:07am
FlashAlert_me @FlashAlert_me
$BCRX: Press Release published article on July 01, 07:15:00: BioCryst Appoints Megan Sniecinski Chief Business Offi… https://t.co/jq9oyPVQNR
July 1st 2019, 7:07am
VisualStockRSRC @VisualStockRSRC
$BCRX - BioCryst Appoints Megan Sniecinski Chief Business Officer https://t.co/QzdruPeiQh
July 1st 2019, 7:07am
StockTipRobot @StockTipRobot
A Nigerian prince emailed and said he'd make me rich! His advice was to #ragetrade BioCryst Pharmaceuticals $BCRX #stocktalk
June 30th 2019, 6:06pm
StockTipRobot @StockTipRobot
Beep boop beep short BioCryst Pharmaceuticals $BCRX #BullMarket
June 29th 2019, 7:06pm
WatchlistN @WatchlistN
Analysts Expect BioCryst Pharmaceuticals, Inc. $BCRX Will Post Quarterly Sales of $2.52 Million https://t.co/39G7BdiIJD
June 29th 2019, 12:06am
IRAMarketReport @IRAMarketReport
Analysts Expect BioCryst Pharmaceuticals, Inc. $BCRX Will Post Quarterly Sales of $2.52 Million https://t.co/49RS65qMne #markets
June 29th 2019, 12:06am
chaffeybreeze @chaffeybreeze
Analysts Expect BioCryst Pharmaceuticals, Inc. $BCRX Will Post Quarterly Sales of $2.52 Million https://t.co/GBYjtA5M9G #stocks
June 29th 2019, 12:06am
Briefingcom @Briefingcom
$BCRX: BioCryst Pharma begins enrollment of Ph 1 trial of BCX9930, an oral factor D inhibitor for... https://t.co/tXS8889VAe
June 27th 2019, 6:06pm
StockNewsNow @StockNewsNow
$BCRX Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Di… https://t.co/Ik2ZutKYp0
June 27th 2019, 5:06pm
ToothFrank @ToothFrank
BioCryst Pharmaceuticals ( $BCRX ) said on Thursday it has begun enrollment of a Phase 1 trial of BCX9930 for the t… https://t.co/sD82BLcnP9
June 27th 2019, 5:06pm
newswelldone @newswelldone
$BCRX: Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral …: https://t.co/8FX9JV5vv7
June 27th 2019, 5:06pm
fintel_io @fintel_io
Also, if you are new to $BCRX here's some background for you https://t.co/eYLYjHsGpC
June 27th 2019, 4:06pm
fintel_io @fintel_io
$BCRX / BioCryst Pharmaceuticals files form 8-K https://t.co/rzpNBdvMaH - Financial Statements and Exhibits, Other Events
June 27th 2019, 4:06pm
filingsdb @filingsdb
New Form 8-K filed by BIOCRYST PHARMACEUTICALS INC $BCRX - https://t.co/oHaWzAdwFZ
June 27th 2019, 4:06pm
VisualStockRSRC @VisualStockRSRC
$BCRX - Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for https://t.co/WzhlquVo26
June 27th 2019, 4:06pm
Allstocknews @Allstocknews
$BCRX Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Media From our Stock News Alerts App
June 27th 2019, 4:06pm
SwingTradeBot @SwingTradeBot
20 DMA Support today: $ACHC $BCRX ... https://t.co/deOpbNqdR6
June 27th 2019, 11:06am
gtgbree @gtgbree
@TheReal_Nayah $bcrx broke college student ?
June 26th 2019, 4:06pm
dakotafinancial @dakotafinancial
Brokerages Expect BioCryst Pharmaceuticals, Inc. $BCRX to Announce -$0.31 Earnings Per Share https://t.co/xo4t7co7st
June 26th 2019, 3:06pm
WKRBNews @WKRBNews
Brokerages Expect BioCryst Pharmaceuticals, Inc. $BCRX to Announce -$0.31 Earnings Per Share https://t.co/L6vCBUTI8p #markets
June 26th 2019, 3:06pm
HeadlinesFin @HeadlinesFin
Biocryst Pharmaceuticals Inc $BCRX Stock Is Shorted Less https://t.co/Gx7ipjUHgh
June 23rd 2019, 6:06am
WeekHerald @WeekHerald
BioCryst Pharmaceuticals $BCRX Sees Large Volume Increase https://t.co/0GObVhfDZY
June 22nd 2019, 12:06am
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals $BCRX Sees Large Volume Increase https://t.co/gdqZZN54h3
June 22nd 2019, 12:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.